Literature DB >> 16569984

Using treatment theories to refine the designs of brain injury rehabilitation treatment effectiveness studies.

John Whyte1.   

Abstract

Many rehabilitation treatments are difficult to define, resulting in a lack of clarity about their essential "active ingredients." Treatment theories can narrow the scope of possible active ingredients, by clearly specifying how the treatment is believed to act. Efficacy studies of theory-defined treatments assess their clinical value, but also advance the science underlying the theory. In addition, treatment theories shape inclusion and exclusion criteria by suggesting what types of patients may benefit, and shape outcome measures by suggesting where the treatment impact should be seen. Finally, treatment theories can assist an investigator in the selection of an optimal study design.

Entities:  

Mesh:

Year:  2006        PMID: 16569984     DOI: 10.1097/00001199-200603000-00003

Source DB:  PubMed          Journal:  J Head Trauma Rehabil        ISSN: 0885-9701            Impact factor:   2.710


  4 in total

1.  The Roles of Retrieval Practice Versus Errorless Learning in Strengthening Lexical Access in Aphasia.

Authors:  Julia Schuchard; Erica L Middleton
Journal:  J Speech Lang Hear Res       Date:  2018-07-13       Impact factor: 2.297

2.  Advancing the evidence base of rehabilitation treatments: a developmental approach.

Authors:  John Whyte; A M Barrett
Journal:  Arch Phys Med Rehabil       Date:  2012-06-07       Impact factor: 3.966

3.  Varied overground walking-task practice versus body-weight-supported treadmill training in ambulatory adults within one year of stroke: a randomized controlled trial protocol.

Authors:  Vincent G DePaul; Laurie R Wishart; Julie Richardson; Timothy D Lee; Lehana Thabane
Journal:  BMC Neurol       Date:  2011-10-21       Impact factor: 2.474

4.  Vocational Rehabilitation in Mild Traumatic Brain Injury: Supporting Return to Work and Daily Life Functioning.

Authors:  Frederik Lehman Dornonville de la Cour; Morten Arendt Rasmussen; Eva Meldal Foged; Line Svenning Jensen; Trine Schow
Journal:  Front Neurol       Date:  2019-02-21       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.